Literature DB >> 1717290

Tachykinin receptors in the guinea-pig isolated bronchi.

C A Maggi1, R Patacchini, L Quartara, P Rovero, P Santicioli.   

Abstract

The aim of the study was to assess which tachykinin receptors mediate the contractile response in the guinea-pig isolated bronchi. Experiments with natural tachykinins and receptor-selective tachykinin agonists were performed in the absence or presence of peptidase inhibitors and in bronchi pretreated with phenoxybenzamine. Both NK-1 (substance P, substance P methylester and septide) and NK-2 (neurokinin A, [beta-Ala8]neurokinin A-(4-10) and MDL 28,564) receptor agonists produced concentration-dependent contraction. NK-3 agonists (senktide and [MePhe7]neurokinin B) were active only at high concentrations. Phenoxybenzamine pretreatment reduced the maximal response to NK-1 agonists and produced a rightward shift of the curve to NK-2 agonists, without depression of the maximum. Five tachykinin antagonists selective for the NK-1 (L 668,169) or the NK-2 (MEN 10,207, MEN 10,376, L 659,877 and R 396) receptor were tested against substance P methylester and [beta-Ala8]neurokinin A-(4-10). The results indicated that these receptor-selective antagonists maintain their characteristic even when tested in a multireceptor assay such as the guinea-pig bronchus. The rank order of potency of NK-2 antagonists against [beta-Ala8]neurokinin A-(4-10) was MEN 10,207 = MEN 10,376 greater than L 659,877 much greater than R 396. This pattern, with the observation of the full agonist activity of MDL 28,564, indicates that in addition to NK-1 receptors, NK-2 receptors also are present in the guinea-pig bronchi and belong to the same subtype (NK-2A) as present in the rabbit pulmonary artery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717290     DOI: 10.1016/0014-2999(91)90517-t

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig.

Authors:  S Daoui; E Naline; V Lagente; X Emonds-Alt; C Advenier
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells.

Authors:  Kentaro Mizuta; George Gallos; Defen Zhu; Fumiko Mizuta; Farida Goubaeva; Dingbang Xu; Reynold A Panettieri; Jay Yang; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-18       Impact factor: 5.464

3.  Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.

Authors:  Y Hirayama; Y H Lei; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.

Authors:  C A Maggi; R Patacchini; A Eglezos; L Quartara; S Giuliani; A Giachetti
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Bronchodilatation by tachykinins and capsaicin in the mouse main bronchus.

Authors:  S Manzini
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Activation of the micturition reflex by NK2 receptor stimulation in the anaesthetized guinea-pig.

Authors:  M Bushfield; M Metcalfe; A M Naylor
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

7.  Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.

Authors:  C A Maggi; R Patacchini; S Meini; L Quartara; A Sisto; E Potier; S Giuliani; A Giachetti
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Tachykinin NK1 receptor subtypes in the rat urinary bladder.

Authors:  S Meini; R Patacchini; C A Maggi
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.